These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36923770)

  • 1. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report.
    Smaoui E; Moalla KS; Bouattour N; Farhat N; Sakka S; Daoud S; Damak M; Mhiri C
    Pan Afr Med J; 2024; 47():46. PubMed ID: 38681104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
    Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
    Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barré Syndrome in an adolescent: A case report.
    Rohilla R; Kakkar AK; Divyashree K; Mohindra R; Suri V
    Br J Clin Pharmacol; 2023 Feb; 89(2):556-560. PubMed ID: 35856283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
    Kanabar G; Wilkinson P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome after coronavirus disease 2019 vaccine: A temporal association.
    da Silva GF; da Silva CF; Oliveira RENDN; Romancini F; Mendes RM; Locks A; Longo MFM; Moro CHC; Longo AL; Braatz VL
    Clin Exp Neuroimmunol; 2022 May; 13(2):92-94. PubMed ID: 34900000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients.
    Karimi N; Boostani R; Fatehi F; Panahi A; Asghar Okhovat A; Ziaadini B; Basiri K; Abdi S; Sinaei F; Rezaei M; Shamsaei G; Ansari B; Nafissi S
    Basic Clin Neurosci; 2021; 12(5):703-710. PubMed ID: 35173924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.
    Kim JE; Min YG; Shin JY; Kwon YN; Bae JS; Sung JJ; Hong YH
    Front Neurol; 2021; 12():820723. PubMed ID: 35153993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.
    Finsterer J
    IDCases; 2021; 25():e01226. PubMed ID: 34290962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome following COVID-19 vaccination: An updated systematic review of cases.
    Shaheen N; Ramadan A; Nashwan AJ; Shaheen A; Ahmad S; Motawea KR; Mohamed S; Mohamed RS; Swed S; Aiash H
    Clin Case Rep; 2023 Jun; 11(6):e7456. PubMed ID: 37305891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
    Yu M; Nie S; Qiao Y; Ma Y
    Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.